FindTrial
Sign In

Study on the effect and mechanism of cancer-cell-biomimetic nanoplatform for targeted clearance of CAF and senescent CAF to improve breast cancer radiotherapy resistance

Study on the effect and mechanism of cancer-cell-biomimetic nanoplatform for targeted clearance of CAF and senescent CAF to improve breast cancer radiotherapy resistance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050062
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

case series:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Histopathologically diagnosed as breast cancer; 3. Breast cancer tissue resection is required; 4. The subjects themselves participated voluntarily and signed the informed consent in writing.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
CAF cells;—

Countries

China

Contacts

Public ContactShi Chen

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

29136909@qq.com+86 15807138405

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026